9 months ago

Marksans Pharma's UK Subsidiary Approved for Pain Relief Tablets

Marksans Pharma's UK Subsidiary Approved for Pain Relief Tablets
Marksans Pharma’s UK arm gets MHRA nod for pain-relief tablets · CNBC TV 18

A company called Marksans Pharma has a branch in the UK.

The UK's health agency has given this branch permission to sell a new medicine called Mefenamic Acid.

This medicine helps with tummy aches and other mild to medium pains.

This is good news for Marksans Pharma because it lets them sell more kinds of medicines in the UK.

The company recently shared its financial results, showing increased sales but a slight dip in profits.

They are hopeful about growing their business in the UK.

Key facts

Company
Marksans Pharma
UK Subsidiary
Relonchem Limited
Regulatory Agency
UK Medicines and Healthcare products Regulatory Agency (MHRA)
Approved Product
Mefenamic Acid Film-Coated Tablets (250 mg and 500 mg)
Indication
Short-term relief of mild to moderate pain, including menstrual pain
Quarterly Financials (Q2 FY26)
Net profit ₹98.2 crore (up 1.5%), Revenue ₹720 crore (up 12%), EBITDA ₹144.7 crore (down 1.7%)

Quotes

Marksans Pharma

A pharmaceutical company headquartered in Mumbai, India

“The drug is used for short-term relief of mild to moderate pain, including menstrual pain”
CNBC TV 18

Sources

Related news